Abstract
Conventional surgical treatment of esophageal carcinoma does not yield a satisfactory outcome. Recurrence is frequently observed in upper mediastinal and/or cervical lymph nodes. Blood-borne metastasis is another factor contributing to the poor prognosis. Considerable effort, including extensive lymph node dissection and chemotherapy, has been directed to improving the long-term survival rate. In our department, the routine surgical treatment for thoracic esophageal carcinoma including adjuvant therapy was changed in 1984, particularly in terms of the extent of lymph node dissection. The aim of this investigation was to analyze the difference in long-term survival achieved with the surgical approaches applied before and after 1984.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Tokyo
About this paper
Cite this paper
Tsurumaru, M., Udagawa, H., Ono, Y., Kajiyama, Y., Akiyama, H. (1993). Surgical Treatment of Intrathoracic Esophageal Carcinoma: Analysis of 481 Cases of Resected Squamous Cell Carcinoma. In: Nabeya, Ki., Hanaoka, T., Nogami, H. (eds) Recent Advances in Diseases of the Esophagus. Springer, Tokyo. https://doi.org/10.1007/978-4-431-68246-2_114
Download citation
DOI: https://doi.org/10.1007/978-4-431-68246-2_114
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-68248-6
Online ISBN: 978-4-431-68246-2
eBook Packages: Springer Book Archive